Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$3.73 - $5.2 $1,861 - $2,594
499 Added 560.67%
588 $2,000
Q3 2022

Nov 14, 2022

BUY
$1.11 - $2.42 $63 - $137
57 Added 178.13%
89 $0
Q3 2021

Nov 15, 2021

SELL
$4.08 - $7.83 $8,004 - $15,362
-1,962 Reduced 98.4%
32 $0
Q2 2021

Aug 16, 2021

BUY
$6.78 - $9.04 $13,519 - $18,025
1,994 New
1,994 $16,000

Others Institutions Holding IMRA

About IMARA Inc.


  • Ticker IMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,287,300
  • Market Cap $552M
  • Description
  • IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...
More about IMRA
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.